CD79A and Stroke: MyD88 signaling is a hallmark of a response to a thymus independent type 1 (TI-1) antigen (Boes, 2000; Hanihara-Tatsuzawa et al., 2014), which indicates that a population of IgA + PCs develop following stroke in response to a TI-2 antigen.